|
Executive Director Report
If you missed last month’s Executive Director Report, it offered a hopeful look at global JM research.
Experts in the United States and Europe are collaborating on new approaches to treatment, including CAR T, JAK inhibitors, and other targeted therapies. Cure JM is helping ensure this knowledge reaches the physicians caring for children today and preparing hospitals for the next generation of clinical trials.
Read the full report for a closer look at this progress.
|